Foscan uptake and tissue distribution in relation to photodynamic efficacy. - Wikidata - wikimedia - TriplyDB

Foscan uptake and tissue distribution in relation to photodynamic efficacy.

Foscan uptake and tissue distribution in relation to photodynamic efficacy.

http://www.wikidata.org/entity/Q36648672

about

Chemophototherapy: An Emerging Treatment Option for Solid Tumors Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis.In vivo quantification of photosensitizer fluorescence in the skin-fold observation chamber using dual-wavelength excitation and NIR imaging.Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window-chamber tumor model.Photochemical internalization of tumor-targeted protein toxins.Optimal treatment opportunity for mTHPC-mediated photodynamic therapy of liver cancer.mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin.Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics.Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals.Strategies for enhanced photodynamic therapy effects.Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer.Microscopic analysis of the localization of two chlorin-based photosensitizers in OSC19 tumors in the mouse oral cavity.Disulfonated tetraphenyl chlorin (TPCS2a), a novel photosensitizer developed for clinical utilization of photochemical internalization.Lower sensitivity of FHC fetal colon epithelial cells to photodynamic therapy compared to HT-29 colon adenocarcinoma cells despite higher intracellular accumulation of hypericin.Bypass of tumor drug resistance by antivascular therapy.Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma.Photodynamic Therapy for Barrett's Esophagus and Esophageal Carcinoma.Modulation of biodistribution, pharmacokinetics, and photosensitivity with the delivery vehicle of a bacteriochlorin photosensitizer for photodynamic therapy.Pharmacokinetics of Photogem Using Fluorescence Spectroscopy in Dimethylhydrazine-Induced Murine Colorectal Carcinoma

P2860

Q28468315-C0157E9A-2EEB-4DA8-881F-647C6E758881 Q33639625-AEBBD855-9997-4751-BBA4-24945C0F0944 Q33807076-352CF3AA-1581-47E9-B42D-132BDDCDFDC0 Q33939506-9DB35693-948F-4EB2-86DF-30C9B5D8A38E Q33962146-D275C28A-D4AB-47CF-A3B8-49313807A165 Q34068201-D444FF8D-9AD2-4C77-9C5F-EF1146886AEF Q34573144-F6F93057-34A4-445C-958E-57C07AA1C432 Q35805252-343F5A3D-4D23-469C-B0BC-6CB143AA085F Q36615900-3B52423B-0105-442D-8F7D-6A95F0113A3E Q36670934-2B9D082B-3FC0-47C7-A92C-8C4A389DBDF4 Q36924496-69E6B753-A364-40ED-866D-BBF45736C678 Q36945978-051FDEF4-8793-41FC-8FC8-86A6BCE5D581 Q37919156-9BF725F2-8B4E-4FAC-972B-DC2F263F2943 Q39033555-9E1796F8-1D23-4266-BD50-5AB9862D40D0 Q39503978-2F7BD218-01BE-43E0-94EF-76D23B09CAC5 Q39596935-9B517A75-EB29-4D42-9FB7-3C28F88C4644 Q41602514-BF7AE60C-B5FB-46A6-A0B5-589A51737234 Q42501576-26054429-AAA5-4845-A3F0-5B60EC98A9F3 Q43247688-9D0B24DA-1288-4E22-AC07-2E95A042C08D Q46953154-C1DED365-88E1-4AFC-B936-A2FEA4FF32F6 Q58688779-8317B16B-9BFB-4504-AE88-D20AB9B2C401

P2860

Foscan uptake and tissue distribution in relation to photodynamic efficacy.

http://www.wikidata.org/entity/Q36648672

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Foscan uptake and tissue distribution in relation to photodynamic efficacy.

@ast

Foscan uptake and tissue distribution in relation to photodynamic efficacy.

@en

type

label

Foscan uptake and tissue distribution in relation to photodynamic efficacy.

@ast

Foscan uptake and tissue distribution in relation to photodynamic efficacy.

@en

prefLabel

Foscan uptake and tissue distribution in relation to photodynamic efficacy.

@ast

Foscan uptake and tissue distribution in relation to photodynamic efficacy.

@en

P1433

Q36648672-E5904294-9E34-4E3A-BE66-EF489FEF67C2

P1476

Q36648672-20F14571-1316-47ED-8FBE-C08168033BDE

P2093

Q36648672-063FAC62-7C01-4CCB-8811-1610EC36DA1F

Q36648672-1C594D33-28DB-4B6A-A297-BB8CC00AFDD1

Q36648672-3DAAB7AC-7696-477D-821F-2E13C2AB8885

Q36648672-4AAFB3E0-E7A4-459B-8BF5-29A8A442F36B

Q36648672-7344DB96-529F-4176-BC3E-3A7AE417D93F

Q36648672-EC5AFA82-2F7D-48B2-ABCE-02BFC69F8C62

P2860

Q36648672-0447D982-9EB3-49A2-9F7F-0730EC6E1E98

Q36648672-0BFD7276-1B75-4F1D-B6C9-D47021660CDB

Q36648672-5F02FB87-FEA1-450D-9238-E7D4581734F2

Q36648672-6952338D-A13E-4720-825A-DC7DDEFF0C3E

Q36648672-70D8325F-0269-4DEB-9F2F-45B78BE3288F

Q36648672-78660472-F3CD-4F76-BF6C-CAAFDC8C6EFA

Q36648672-858B979A-CEBC-4CB6-840E-AB80D2FC7B69

Q36648672-8BF0FC4C-66FD-4D5B-B7E9-3AA545D7E3BF

Q36648672-B4C68747-0C7C-4851-BB49-8E934AC3B3A7

Q36648672-B9C93BD2-0C2D-4413-AEE6-B2FA6AB39BE9

P2888

Q36648672-E345BE54-92CE-467E-9620-93DE49E83DCB

P304

Q36648672-439E605D-14FB-4D7B-A664-3F0F694C2F7F

P31

Q36648672-108F314F-CA60-4987-8C8F-7A8E542F328F

P356

Q36648672-CE71C349-DE37-4BEE-B710-7FB8CDC518C4

P407

Q36648672-6AF3B9B1-EF42-418E-B340-25037CAD68D1

P433

Q36648672-7829C802-F3A8-4CEB-A2E5-6B73098C541D

P478

Q36648672-31146271-77A1-4538-9D8B-D819A80BD898

P577

Q36648672-20685872-492D-4531-A03F-30942E3609BF

P5875

Q36648672-502E9427-7072-40C0-984F-AB2C852EC314

P698

Q36648672-ABC1DFE7-F898-4318-84C1-F2C4943DEE25

P932

Q36648672-C2227CFE-7109-4127-A13E-742448072B6B

P356

P1433

British Journal of Cancer

P1476

Foscan uptake and tissue distribution in relation to photodynamic efficacy.

@en

P2093

F A Stewart

http://www.w3.org/2001/XMLSchema#string

H Oppelaar

http://www.w3.org/2001/XMLSchema#string

M Ruevekamp

http://www.w3.org/2001/XMLSchema#string

O Dalesio

http://www.w3.org/2001/XMLSchema#string

P Baas

http://www.w3.org/2001/XMLSchema#string

P Cramers

http://www.w3.org/2001/XMLSchema#string

P2860

Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue

Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results.

Laser-induced fluorescence studies of meso-tetra(hydroxyphenyl)chlorin in malignant and normal tissues in rats

Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.

Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.

Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.

Correlation between meta(tetrahydroxyphenyl)chlorin (m-THPC) biodistribution and photodynamic effects in mice.

Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma.

Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.

Photodynamic therapy using mTHPC for malignant disease in the oral cavity.

P2888

P304

283-290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6600682

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10878629

http://www.w3.org/2001/XMLSchema#string

P698

12610515

http://www.w3.org/2001/XMLSchema#string

P932

2377038

http://www.w3.org/2001/XMLSchema#string